MUFG has announced the appointment of Nauman Ansari as an Executive Director of the bank's healthcare finance business in EMEA.
Nauman, who joins from Morgan Stanley, brings a wealth of healthcare and leveraged and acquisition finance experience to MUFG. He played a significant role in a number of transformative transactions for Shire on the acquisitions of Baxalta Inc, Dyax Corporation, and Viropharma.
Ian Wootton, Managing Director of the Healthcare division, EMEA, said:
"MUFG is committed to the healthcare industry, and Nauman's significant industry expertise will enhance our ability to offer innovative and relevant solutions, and to grow client relationships. We are delighted that he has joined the team."
Nauman's appointment forms a key part of MUFG's ongoing strategy to bolster the healthcare finance business as opportunities in the market grow, with another new team member due to join over the next few months.
Nauman's role will focus on consolidating and strengthening MUFG's current healthcare clients, and building new relationships to expand the bank's global network. Prior to his time at Morgan Stanley, Nauman held senior roles at Bank of America Merrill Lynch and Lehman Brothers in the UK and the US.
Nauman will be based in London and begins his role with immediate effect.